Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
OBJECTIVE
Response of quiescent (Q) and total tumor cells in solid tumors to neutron irradiation with three different cadmium (Cd) ratios was examined. The role of Q cells in tumor control was also discussed.


METHODS
C3H/He mice bearing SCC VII tumors received continuous administration of 5-bromo-2'-deoxyuridine (BrdU) for 5 days using implanted mini-osmotic pumps to label all proliferating (P) cells. Thirty minutes after intraperitoneal injection of sodium borocaptate-10B (BSH), or 3 h after oral administration of dl-p-boronophenylalanine-10B (BPA), the tumors were irradiated with neutrons, or those without 10B-compounds were irradiated with gamma rays. This neutron irradiation was performed using neutrons with three different cadmium (Cd) ratios. The tumors were then excised, minced, and trypsinized. The tumor cell suspensions were incubated with cytochalasin-B (a cytokinesis-blocker), and the micronucleus (MN) frequency in cells without BrdU labeling (Q cells) was determined using immunofluorescence staining for BrdU. The MN frequency in total (P + Q) tumor cells was determined from tumors that were not pretreated with BrdU. The sensitivity to neutrons was evaluated in terms of the frequency of induced micronuclei in binuclear tumor cells (MN frequency).


RESULTS
Without 10B-compounds, the MN frequency in Q cells was lower than that in the total cell population. The sensitivity difference between total and Q cells was reduced by neutron irradiation. Relative biological effectiveness (RBE) of neutrons compared with gamma rays was larger in Q cells than in total cells, and the RBE values for low-Cd-ratio neutrons tended to be larger than those for high-Cd-ratio neutrons. With 10B-compounds, MN frequency for each cell population was increased, especially for total cells. This increase in MN frequency was marked when high-Cd-ratio neutrons were used. BPA increased the MN frequency for total tumor cells more than BSH. Nevertheless, the sensitivity of Q cells treated with BPA was lower than that in BSH-treated Q cells. This tendency was clearly observed in high-Cd-ratio neutrons.


CONCLUSIONS
From the viewpoint of enhancing the Q-cell sensitivity, tumors should be irradiated with high-Cd-ratio neutrons after BSH administration. However, normal tissue reaction remains to be examined because of its low tumor-to-normal tissue and tumor-to-blood biodistribution ratios.
Radiation Oncology Research Laboratory, Kyoto University, Osaka, Japan.
S
S
Masunaga
K
K
Ono
Y
Y
Sakurai
M
M
Takagaki
T
T
Kobayashi
M
M
Suzuki
Y
Y
Kinashi
M
M
Akaboshi
D000818:Animals; D001894:Borohydrides / Q000008:administration & dosage; D001896:Boron Compounds / Q000008:administration & dosage; D016754:Boron Neutron Capture Therapy; D001973:Bromodeoxyuridine / Q000032:analysis; D002106:Cadmium Radioisotopes / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000532:radiotherapy*; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D004735:Energy Transfer; D005260:Female; D005720:Gamma Rays / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D015162:Micronucleus Tests; D010649:Phenylalanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D012062:Relative Biological Effectiveness; D013438:Sulfhydryl Compounds / Q000008:administration & dosage
D001894:Borohydrides; D001896:Boron Compounds; D002106:Cadmium Radioisotopes; D013438:Sulfhydryl Compounds; C014651:mercaptoundecahydrododecaborate; D010649:Phenylalanine; D001973:Bromodeoxyuridine; C033685:4-boronophenylalanine